View drug registration information details.
| Items | Registration information |
|---|
| ID | 900 |
|---|
| No | 900 |
|---|
| Brand Name | DABRAMAKS 75 |
|---|
| Ingredients | DABRAFENIB 75 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | 120 TABLETS/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | BRAF V600E MUTATION-POSITIVE UNRESECTABLE OR MEATASTATIC MELANOMA, MUTATION-POSITIVE METASTATIC NSCLC |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE CAPSULE CONTAINS WHITE GRANULE |
|---|
| Note | |
|---|
| License Owner | FACTORY NO.2 |
|---|
| Manufacturer | FACTORY No.2 |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 12 L 1044/23 |
|---|
| FDD Registration Date | 15-Dec-2023 |
|---|
| Expiry Date | 14-Dec-2026 |
|---|
Back to drug list
|
